What is the current state of vaccine development for COVID-19? And what are the key pricing and adoption challenges? Journalist Beth Snyder Bulik discussed these issues with Jane, quoted in the article on U.S. health consumers’ growing concerns about taking advantage of a vaccine for the coronavirus.
Jane quoted in FiercePharma on the promise and pitfalls for a COVID-19 vaccine
By Jane Sarasohn-Kahn on 16 June 2020 in
I’m celebrating America’s 250th birthday both patriotically and professionally, honored that the NLM included my 2010 paper, “How Smartphones Are Changing Healthcare for Consumers and Patients” as one of 250 items curated for the digital archive of 250 Years of American Medicine.
I'm grateful to be part of the Duke Corporate Education faculty, sharing perspectives on the future of health care with health and life science companies. Once again, I'll be brainstorming the future of health care with a cohort of executives working in a global health care enterprise.
Jane joined host Dr. Geeta "Dr. G" Nayyar and colleagues to brainstorm the value of vaccines for public and individual health in this challenging environment for health literacy, health politics, and health citizen grievance. Click onto the Pfizer Value of Vaccines site and you can watch four episodes covering the challenges with adult vaccination, the employer and health plan member's journey to vaccination, reimbursement, and collaborating for proactive prevention.